NCT02388971View on ClinicalTrials.gov

Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Atherosclerotic Cardiovascular Disease

Interventions

DRUG

MLN1202

MLN1202 solution

DRUG

Placebo

MLN1202 placebo-matching solution

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY